FDA approves Roivant drug, the first novel topical plaque psoriasis med in 25 years
Plaque psoriasis drug Vtama is now approved by the FDA, making it the first novel topical treatment for the chronic autoimmune disorder in a generation. […]
autoimmune diseases
Flagship merges two of its biotechs to form cellular microenvironment-focused Sonata
Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, […]
Startup Nuvig Therapeutics gets $47M to bring immune system back into balance
Nuvig Therapeutics is developing drugs that tap into one of the body’s natural mechanisms for controlling inflammation. Co-founder and CEO Pamela Conley, a veteran of […]
Topical Aloe Vera Gel for Lichen Planus
We shouldn’t ever swallow aloe vera, but how does using it topically for a chronic inflammatory autoimmune disease compare to steroids? Lichen planus is a […]
Alopecia Hair Loss: What to Know About Jada Pinkett Smith’s Condition
Jada Pinkett Smith’s hair loss condition played a major role in an incident at the Oscars. Here’s what we know about it.
Seizing “magic moment” for machine learning, startup Seismic unveils $101M
Machine learning is core to the drug research of Seismic Therapeutic, a new biotech startup developing novel drugs for immunology indications. CEO Jo Viney said […]
Pfizer: $6.7B Arena buyout complements rather than replaces JAK drugs
Sales of blockbuster Pfizer drug Xeljanz are under pressure from a stronger safety warning placed across that drug’s entire class. In acquiring Arena Pharmaceuticals for […]
Synbio startup GRObio gets $25M to work with new building blocks for protein drugs
Harvard University spinout GRO Biosciences has technology offering the potential for protein therapies that are safer and more effective than currently available biologic drugs. The […]
Merck Entered into a WW Research Collaboration and License Agreement with Synthekine to Develop Novel Cytokine Therapeutics
Shots: Synthekine to receive up front along with an additional one-time payment, if selects a second target & will be eligible for ~$525M in development, […]
Curing Canker Sores with Diet
Does excluding dairy products, food additives, and gluten-containing grains from one’s diet help those with recurring canker sores (aphthous ulcers)? Recurring canker sores are the […]
Xilio, Ventyx IPOs raise $269M to fuel plans to compete with big pharma drugs
Cancer drug developer Xilio Therapeutics and Ventyx Biosciences, a company with drug candidates in cancer and autoimmune diseases, are the latest life science companies to […]
Already allied with Takeda, Egle raises €40M for its ‘starving’ immunotherapy
In less than two years, Egle Therapeutics launched, partnered with Takeda Pharmaceutical, and found its first cancer targets. Now the startup has €40M in Series […]
Tentarix Bio unveils $50M for biologics with multiple functions, multiple targets
Biotech startup Tentarix Biotherapeutics has come out of stealth with $50 million and technology that develops biologic drugs endowed with multiple functions. The company aims […]
With FDA nod, ChemoCentryx pill stands out in a sea of injectable & infused meds
ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA […]
Despite drug’s Phase 2 failure in ulcerative colitis, BMS keeps blockbuster hopes
Bristol Myers Squibb drug deucravacitinib missed the main and secondary goals of a Phase 2 study in ulcerative colitis. Despite the clinical trial failure, the […]
Dice’s IPO roll comes up with $204M for R&D of oral drugs to rival biologics
Dice Therapeutics raised $204 million from its IPO to support development of oral drugs that could compete against biologic drugs that are injected or infused. […]
Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million people in the USA are affected by autoimmune diseases such as rheumatoid arthritis, […]
Quest to Help Diabetic Son Endures With a Different Kind of Giving
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
Quest to Help Diabetic Son Endures With a Different Kind of Giving
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
Quest to Help Diabetic Son Endures With a Different Kind of Giving
Sean Doherty set up a private equity-like fund with other parents four years ago. Some investments in research have worked. Some haven’t.
Apellis taps Beam’s base-editing tech to broaden autoimmune disease scope
Fresh off its first FDA approval, Apellis Pharmaceuticals is teaming up with Beam Therapeutics, a partnership that will use Beam’s base-editing technology to develop new […]
What’s Best for Eczema (Atopic Dermatitis): Coconut Oil vs. Mineral Oil vs. Vaseline
Natural topical remedies for eczema, including licorice root gel, St. John’s Wort cream, and emollients such as coconut oil, mineral oil, and petroleum jelly, are […]
Dietary Supplements for Eczema (Atopic Dermatitis)
Are there dietary supplements that can help with atopic dermatitis? Atopic dermatitis, more commonly known as eczema, ranks “as the skin disease with the greatest […]
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Vaccines Won’t Protect Millions of Patients With Crippled Immune Systems
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Biotech startup Repertoire adds $189M to expand array of immune medicines
With two cancer programs already making progress, Repertoire Immune Medicines will use the Series B financing to expand its immune synapse research to autoimmune disorders […]
Merck commits $1.85B to Pandion in bid to boost immunology pipeline
Merck’s top immunology drugs face biosimiliar competition. The $1.85 billion acquisition of Pandion Therapeutics gives the pharma giant an opportunity to build up its immunology […]
Dietary Cure for Hidradenitis Suppurativa
What is the role of dairy- and yeast-exclusion diets on arresting and reversing an inflammatory autoimmune disease? A landmark study suggested that exposure to dietary […]
Is Nutritional Yeast Healthy for Everyone?
Those with certain autoimmune diseases such as Crohn’s disease should probably not eat nutritional yeast. Thousands of years ago, some yeast floated down into our […]
Is Candida Syndrome Real?
Does the presence of Candida in stool correlate with “Candida-hypersensitivity” symptoms, such as headaches and tiredness? And what happens when people are placed on a […]
Does Nutritional Yeast Trigger Crohn’s Disease?
Is the exaggerated reaction of many Crohn’s disease patients to baker’s, brewer’s, and nutritional yeast just a consequence of their inflamed leaky gut, or might […]
One Way to Treat Asthma and Autoimmune Diseases with Diet
Cutting two teaspoons of salt’s worth of sodium from one’s daily diet can significantly improve lung function in asthmatics In the 1960s and 1970s, a […]
How to Prevent the Infection that May Trigger Type 1 Diabetes
The compelling finding of Mycobacterium avium paratuberculosis (MAP) circulating disproportionately within the bloodstream of type 1 diabetics was subsequently confirmed by culturing it straight out […]
The Role of Meat and Dairy in Triggering Type 1 Diabetes
Type 1 diabetes “arises following the autoimmune destruction of the insulin-producing pancreatic β [beta] cells…[and] is most often diagnosed in children and adolescents, usually presenting […]
